
He has published multiple articles and spoken widely on immuno-oncology agents, side-effect management, and cancer-related distress. In addition to his clinical work, Matthew is a member of the clinical faculty at the Yale School of Nursing. His personal research interest is on developing evidence-based guidelines for the management of side-effects from immune therapy for cancer and on cancer-related distress.